Abstract:Purpose: Diabetic retinopathy (DR) is one of the most common diabetic microvascular complications. However, the pathogenesis of DR has not yet been fully elucidated. This study aimed to discover novel and key molecules involved in the pathogenesis of DR, which could potentially be targets for therapeutic DR intervention. Methods: To identify potential genes involved in the pathogenesis of DR, we analyzed the public database of neovascular membranes (NVMs) from patients with proliferative diabetic retinopathy (PDR) and healthy controls (HCs) (GSE102485, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE102485 ). Further, we compared these findings by performing RNA-sequencing analysis of peripheral blood mononuclear cells (PBMC) from patients with DR, control patients with non-complicated diabetes mellitus (DMC), and HCs. To determine the critical role of candidate genes in DR, knockdown or knockout was performed in human retinal vascular endothelial cells (HRVECs). The oxidative stress pathway, as well as tight junction integrity, was analyzed. Results: Transcriptional profiles showed distinct patterns between the NVMs of patients with DR and those of the HCs. Those genes enriched in either extracellular matrix (ECM)-receptor interaction or focal adhesion pathways were considerably upregulated. Both pathways were important for maintaining the integrity of retinal vascular structure and function. Importantly, the gene encoding the matricellular protein CCN1, a key gene in cell physiology, was differentially expressed in both pathways. Knockdown of CCN1 by small interfering RNA (siRNA) or knockout of CCN1 by the CRISPR-Cas9 technique in HRVECs significantly increased the levels of VE-cadherin, reduced the level of NADPH oxidase 4 (NOX4), and inhibited the generation of reactive oxygen species (ROS). Conclusion: The present study identifies CCN1 as an important regulator in the pathogenesis of DR. Increased expression of CCN1 stimulates oxidative stress and disrupts tight junction integrity in endothelial cells by inducing NOX4. Thus, targeting the CCN1/NOX4 axis provides a therapeutic strategy for treating DR by alleviating endothelial cell injury.

Canonical Wnt Signaling in Diabetic Retinopathy.

Possible Role of Wnt Signaling Pathway in Diabetic Retinopathy

Inflammatory Machenism in the Pathogenesis of Diabetic Retinopathy

Activation of the Wnt Pathway Plays a Pathogenic Role in Diabetic Retinopathy in Humans and Animal Models.

Wnt Signaling in vascular eye diseases

Selective Activation of the Wnt-Signaling Pathway as a Novel Therapy for the Treatment of Diabetic Retinopathy and Other Retinal Vascular Diseases

Autophagy Positively Regulates Wnt Signaling in Mice with Diabetic Retinopathy.

The pathophysiological mechanisms underlying diabetic retinopathy

Mechanistic and therapeutic perspectives of non-coding RNA-modulated apoptotic signaling in diabetic retinopathy

The Pathogenic Role of the Canonical Wnt Pathway in Age-Related Macular Degeneration

A review of the role of the Wnt signaling pathway in eye development and ophthalmic diseases

An overview of the pathogenesis of diabetic retinopathy

Diabetic Retinopathy: Pathophysiology and Treatments

Diabetic Retinopathy: From Animal Models to Cellular Signaling

Diabetic retinopathy: Involved cells, biomarkers, and treatments

Diabetes Promotes Retinal Vascular Endothelial Cell Injury by Inducing CCN1 Expression

A Glimpse of the Pathogenetic Mechanisms of Wnt/β-Catenin Signaling in Diabetic Nephropathy

Molecules related to diabetic retinopathy in the vitreous and involved pathways

The role of Keap1-Nrf2 signaling pathway during the progress and therapy of diabetic retinopathy

The signaling pathways of traditional Chinese medicine in treating diabetic retinopathy